AN ADULT HUMAN body consists of some 37trn cells. Not so long ago, these were thought to come in 220 different types. That number, the product of painstaking decades spent peering through microscopes ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%. The data ...

LONDON, Ontario and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell ...

Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...

Two studies unveiled at the 85th Scientific Sessions of the American Diabetes Association in Chicago point to progress in developing stem cell-based treatments for type 1 diabetes. One study evaluated ...